Consistent with the combined effect observed with APVAC1 and APVAC2, this vaccine elicited the generation of circulating polyfunctional neoantigen‐specific CD4+ and CD8+ T cell responses, enriched in a memory phenotype, and increased infiltration of T cells into the tumor. The gene discussed is CD4; the disease is neoplasm.